Effectiveness of Occupational Therapy in Patients With Rheumatoid Arthritis(RCT)
NCT ID: NCT00400868
Last Updated: 2010-02-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
54 participants
INTERVENTIONAL
2006-07-31
2009-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Work Interventions to Improve Employment Outcomes for Persons With Rheumatoid Arthritis and Osteoarthritis
NCT00485914
Hand Exercises for Women With Rheumatoid Arthritis and Impaired ADL Ability: an Exploratory Trial
NCT02140866
Is Fluidotherapy Effective in Rheumatoid Hand?
NCT03127969
Fatigue in People With Rheumatoid Arthritis- Randomized Controlled Trial
NCT02120963
Physical Activity Behavior of Rheumatoid Arthritis Patients and Healthy Controls
NCT01228812
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The effectiveness of JP has been evaluated in a number of studies, all in a group setting. JP has beneficial short-term effects on pain and function in patients with established RA and moderate functional problems. Using assistive devices reduces pain during task performance in comparison to normal methods and altering working methods significantly reduces difficulties in activities of daily living (ADL). However this generally does not result in significant behavioral changes and a long-term impact on reducing pain and maintaining function may only be reached if JP is taught using behavioral education methods. Additionally, adherence of RA patients to different interventions is generally modest, which may well determine the effectiveness of any given intervention, especially in the long-term.
All previous studies were carried out in group settings, however, in Switzerland, standard JP education is provided on a one-to-one basis and an individualized education is assumed to be a promising approach.
This clinical trial aims to test the hypothesis that an individualized, resource-oriented JP education in RA patients leads to a better therapy success in the short and long-term, compared to problem-oriented standard JP education in terms of joint protection behavior. Secondary outcome parameters are self-perception, general and specific self-efficacy and general and health-related quality of life.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
standard joint protection education
psycho-educational joint protection vs. usual care (standard joint protection education)
psycho-educational Joint protection education
individualized psycho-educational joint protection education, 4-times over 3 weeks; one additional booster session 2 months later
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
psycho-educational Joint protection education
individualized psycho-educational joint protection education, 4-times over 3 weeks; one additional booster session 2 months later
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Actual hand pain on activity or history of wrist and/or metacarpophalangeal(MCP) joint pain and inflammation
* Referred to OT for a Joint Protection intervention program
* Willingness to comply with the randomly assigned treatment and informed consent
* Functional Class: 2 to 4
* German speaking/understanding/reading
* Sufficient cognitive capacities to understand the aims and procedures of the proposed study and the requirements of participation
Exclusion Criteria
* Severe finger, hand, elbow or shoulder deformities
* Insufficient ability to understand, speak and read the German language
* Insufficient cognitive capacities to understand the aims and procedures of the proposed study and the requirements of participation.
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zürcher Rheumastifung, Zurich, Switzerland
OTHER
Gertrude and Wolfgang Schrader Dislich Foundation
OTHER
Swiss Ligue Against Rheumatism, Zurich, Switzerland
UNKNOWN
University of Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
University Hospital Zurich
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert de Bie, Prof, PhD
Role: STUDY_DIRECTOR
University of Maastricht NL
Karin Niedermann, MPH
Role: PRINCIPAL_INVESTIGATOR
University Hospital of Zurich, CH
Stefan Buchi, MD
Role: STUDY_DIRECTOR
University Hospital of Zurich, CH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital
Bern, , Switzerland
Rehabilitation Clinic
Valens, , Switzerland
Schulthess Klinik
Zurich, , Switzerland
University Hospital
Zurich, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
niedk_EK444_
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.